Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Sep 9, 2013 schleifer leonard s Officer Automatic Buy 5,000 n/a
Sep 9, 2013 schleifer leonard s Officer Automatic Sell 5,000 275.04 - 277.12
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
Aug 22, 2013 ryan arthur f Director Option Execute 30,000 18.61 - 57.11
Aug 14, 2013 goldstein joseph l Director Acquisition (Non Open Market) 5,000 n/a
Aug 1, 2013 goldberg murray a Officer Option Execute 5,000 16.80
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Jun 17, 2013 aberman michael s Officer Option Execute 3,900 24.00
Jun 13, 2013 roberts william Officer Acquisition (Non Open Market) 4,000 n/a
Jun 13, 2013 roberts william Officer Disposition (Non Open Market) 4,000 n/a
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
May 21, 2013 goldberg murray a Officer Disposition (Non Open Market) 4,061 n/a
May 21, 2013 goldberg murray a Officer Option Execute 4,023 16.80 - 20.32
May 21, 2013 goldberg murray a Officer Automatic Sell 66,835 255.52 - 264.61
Showing 141-160 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)